Breast cancer survivors can lose weight through modest lifestyle changes
the ONA take:
Female breast cancer survivors may be able to lose weight through modest lifestyle changes, according to a recent study presented at the American Society of Clinical Oncology (ASCO) 2015 meeting in Chicago.
Tim Byers, MD, MPH, of the University of Colorado Cancer Center and fellow researchers looked at 700 women at four sites around the U.S. for two years as part of a randomized control trial in which half of the participants underwent lifestyle interventions.
“The goal was to lose seven percent of their body weight and maintain it for two years,” said study collaborator Rebecca Sedjo, PhD. The women in the intervention group attended motivational meetings which focused on increasing physical activity and decreasing caloric intake.
Within the first 12 months, average weight loss among the participants in the intervention group was six percent of total body weight.
“This is a significant finding because it shows that women are able to lose weight after breast cancer treatment and this may lead to reduced risk of recurrence,” said Dr. Byers.
Female breast cancer survivors may be able to lose weight through modest lifestyle changes.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|